Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

6 Quality Biotech Stocks on Sale Now


Who doesn't love a good sale? With the markets in turmoil and little idea when it will end, healthcare investors can seize the opportunity to snap up discounted shares of quality companies.

Here, I explore six attractive small and mid-cap biotechs with valuations greater than $5.5 billion. These established companies expect to generate revenue between $450 million and $2.4 billion in 2020. Yet due to market conditions, their stock prices have dropped between 10% and 35% this year.

Image Source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments